BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 35176169)

  • 1. Adherence to the 4S-AF Scheme in the Balkan region: Insights from the BALKAN-AF survey.
    Kozieł-Siołkowska M; Mihajlovic M; Nedeljkovic M; Pavlovic N; Paparisto V; Music L; Trendafilova E; Dan AR; Kusljugic Z; Dan GA; Lip GY; Potpara TS
    Kardiol Pol; 2022; 80(4):461-467. PubMed ID: 35176169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quality indicators in the management of atrial fibrillation: the BALKAN-AF survey.
    Kozieł M; Mihajlovic M; Nedeljkovic M; Pavlovic N; Paparisto V; Music L; Trendafilova E; Dan AR; Kusljugic Z; Dan GA; Lip GYH; Potpara TS;
    Int J Cardiol; 2021 Jun; 333():105-109. PubMed ID: 33621622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stroke prevention in atrial fibrillation and 'real world' adherence to guidelines in the Balkan Region: The BALKAN-AF Survey.
    Potpara TS; Dan GA; Trendafilova E; Goda A; Kusljugic Z; Manola S; Music L; Musetescu R; Badila E; Mitic G; Paparisto V; Dimitrova ES; Polovina MM; Petranov SL; Djergo H; Loncar D; Bijedic A; Brusich S; Lip GY;
    Sci Rep; 2016 Feb; 6():20432. PubMed ID: 26869284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Patterns of Non-vitamin K Antagonist Oral Anticoagulants (NOACs) Use in Patients with Atrial Fibrillation in Seven Balkan Countries: a Report from the BALKAN-AF Survey.
    Potpara TS; Trendafilova E; Dan GA; Goda A; Kusljugic Z; Manola S; Music L; Gjini V; Pojskic B; Popescu MI; Georgescu CA; Dimitrova ES; Kamenova D; Ekmeciu U; Mrsic D; Nenezic A; Brusich S; Milanov S; Zeljkovic I; Lip GYH;
    Adv Ther; 2017 Aug; 34(8):2043-2057. PubMed ID: 28795332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contemporary Trends in Oral Anticoagulant Prescription in Atrial Fibrillation Patients at Low to Moderate Risk of Stroke After Guideline-Recommended Change in Use of the CHADS
    Katz DF; Maddox TM; Turakhia M; Gehi A; O'Brien EC; Lubitz SA; Turchin A; Doros G; Lei L; Varosy P; Marzec L; Hsu JC
    Circ Cardiovasc Qual Outcomes; 2017 May; 10(5):. PubMed ID: 28506981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stroke and bleeding risk scores in patients with atrial fibrillation and valvular heart disease: evaluating 'valvular heart disease' in a nationwide cohort study.
    Lip GYH; Jensen M; Melgaard L; Skjøth F; Nielsen PB; Larsen TB
    Europace; 2019 Jan; 21(1):33-40. PubMed ID: 29986001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Symptom management strategies: Rhythm vs rate control in patients with atrial fibrillation in the Balkan region: Data from the BALKAN-AF survey.
    Kozieł M; Mihajlovic M; Nedeljkovic M; Pavlovic N; Paparisto V; Music L; Trendafilova E; Rodica Dan A; Kusljugic Z; Dan GA; Lip GYH; Potpara TS;
    Int J Clin Pract; 2021 Jun; 75(6):e14080. PubMed ID: 33548075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of patients with newly-diagnosed atrial fibrillation: Insights from the BALKAN-AF survey.
    Kozieł M; Simovic S; Pavlovic N; Nedeljkovic M; Paparisto V; Music L; Goshev E; Dan AR; Manola S; Kusljugic Z; Trendafilova E; Dobrev D; Dan GA; Lip GYH; Potpara TS;
    Int J Cardiol Heart Vasc; 2020 Feb; 26():100461. PubMed ID: 32140551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical utility and prognostic implications of the 4S-AF scheme: Report from Asia Pacific Heart Rhythm Society Atrial Fibrillation Registry.
    Chao TF; Tse HF; Teo WS; Park HW; Shimizu W; Chen SA; Lip GYH;
    Eur J Clin Invest; 2022 Oct; 52(10):e13825. PubMed ID: 35700114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of Oral Anticoagulation in a Real-World Population With Device Detected Atrial Fibrillation.
    Kaplan RM; Ziegler PD; Koehler J; Landman S; Sarkar S; Passman RS
    J Am Heart Assoc; 2020 Dec; 9(24):e018378. PubMed ID: 33252286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of atrial fibrillation in patients with chronic kidney disease in clinical practice: a joint European Heart Rhythm Association (EHRA) and European Renal Association/European Dialysis and Transplantation Association (ERA/EDTA) physician-based survey.
    Potpara TS; Ferro C; Lip GYH; Dan GA; Lenarczyk R; Mallamaci F; Ortiz A; Sarafidis P; Ekart R; Dagres N
    Europace; 2020 Mar; 22(3):496-505. PubMed ID: 31965154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reasons for and consequences of oral anticoagulant underuse in atrial fibrillation with heart failure.
    Savarese G; Sartipy U; Friberg L; Dahlström U; Lund LH
    Heart; 2018 Jul; 104(13):1093-1100. PubMed ID: 29371374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Practice Gap in Atrial Fibrillation Oral Anticoagulation Prescribing at Emergency Department Home Discharge.
    Kea B; Waites BT; Lin A; Raitt M; Vinson DR; Ari N; Welle L; Sill A; Button D; Sun BC
    West J Emerg Med; 2020 Jun; 21(4):924-934. PubMed ID: 32726266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stroke prevention in elderly patients with non-valvular atrial fibrillation in the BALKAN-AF survey.
    Potpara TS; Simovic S; Pavlovic N; Nedeljkovic M; Paparisto V; Music L; Goshev E; Loncar D; Popescu R; Manola S; Kusljugic Z; Trendafilova E; Dan GA; Lip GYH
    Eur J Clin Invest; 2020 Mar; 50(3):e13200. PubMed ID: 31953953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of Nonagenarians With Atrial Fibrillation: Insights From the Berlin Atrial Fibrillation (BAF) Registry.
    Wutzler A; von Ulmenstein S; Attanasio P; Huemer M; Parwani AS; Boldt LH; Haverkamp W
    J Am Med Dir Assoc; 2015 Nov; 16(11):969-72. PubMed ID: 26123257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral Anticoagulation and the Risk of Stroke or Death in Patients With Atrial Fibrillation and One Additional Stroke Risk Factor: The Loire Valley Atrial Fibrillation Project.
    Fauchier L; Lecoq C; Clementy N; Bernard A; Angoulvant D; Ivanes F; Babuty D; Lip GY
    Chest; 2016 Apr; 149(4):960-8. PubMed ID: 26425935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between device-detected burden and duration of atrial fibrillation and risk of ischemic stroke.
    Al-Gibbawi M; Ayinde HO; Bhatia NK; El-Chami MF; Westerman SB; Leon AR; Shah AD; Patel AM; De Lurgio DB; Tompkins CM; Lloyd MS; Merchant FM; Kiani S
    Heart Rhythm; 2021 Mar; 18(3):338-346. PubMed ID: 33250442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adherence to treatment guidelines: the association between stroke risk stratified comparing CHADS
    Chapman SA; St Hill CA; Little MM; Swanoski MT; Scheiner SR; Ware KB; Lutfiyya MN
    BMC Health Serv Res; 2017 Feb; 17(1):127. PubMed ID: 28187730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of multimorbidity and polypharmacy on the management of patients with atrial fibrillation: insights from the BALKAN-AF survey.
    Kozieł M; Simovic S; Pavlovic N; Kocijancic A; Paparisto V; Music L; Trendafilova E; Dan AR; Kusljugic Z; Dan GA; Lip GYH; Potpara TS
    Ann Med; 2021 Dec; 53(1):17-25. PubMed ID: 32700579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incident Co-Morbidities in Patients with Atrial Fibrillation Initially with a CHA2DS2-VASc Score of 0 (Males) or 1 (Females): Implications for Reassessment of Stroke Risk in Initially 'Low-Risk' Patients.
    Chao TF; Liao JN; Tuan TC; Lin YJ; Chang SL; Lo LW; Hu YF; Chung FP; Chen TJ; Lip GYH; Chen SA
    Thromb Haemost; 2019 Jul; 119(7):1162-1170. PubMed ID: 30900222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.